Eye drop study reveals hidden link between bacteria and dry eye relief

NCT ID NCT06936462

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 2 times

Summary

This completed study looked at how two types of eye drops—cyclosporine A and hyaluronic acid—change the community of bacteria living on the eye's surface in people with dry eye syndrome. Fifty adults were randomly assigned to receive either cyclosporine plus hyaluronic acid or hyaluronic acid alone for 12 weeks. Researchers collected eye surface samples and measured symptoms using standard questionnaires. The goal was to see if changes in the eye's microbiome relate to symptom improvement.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
cyclosporine A and hyaluronic acid eye drops
What this could lead to
If successful, this could help explain how the eye's natural bacteria influence dry eye symptoms and point toward microbiome-based treatments.
What could go wrong
This is a small, early-stage study with only 50 participants and high dropout. Results may not apply to all dry eye patients, and the microbiome findings are exploratory.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRY EYE SYNDROME (DES) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hallym University, Kangnam Sacred Heart Hospital

    Seoul, Seoul, 07441, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.